
ACIC
$ACIC Director's $110,000 Purchase Following Stock Decline Contrasts With Executives' Selling Pattern
05/19/2025 20:25
Sentiment
Summary
- Director Sherrill Hudson purchased 10,000 shares ($110,000) of $ACIC on May 15, while executives have consistently been selling shares since early 2025.
- ACIC's Q1 2025 adjusted EPS of $0.42 beat expectations but declined 16% year-over-year, with the combined ratio worsening to 65%.
- Analysts maintain a 'buy' rating with a $16 price target, and the company's recent sale of its personal lines subsidiary appears to be a strategic move to focus on core business areas.
POSITIVE
- Consistent share purchases by directors indicate insider confidence in the company's long-term value at current price levels.
- The 65% combined ratio, while deteriorated, remains excellent by industry standards and suggests sound underwriting discipline.
- The special dividend of $0.50 per share in December 2024 demonstrates management's commitment to shareholder returns.
- Analyst price target of $16 suggests a 45% upside potential from current levels.
- The low P/E ratio of 7.57 indicates potential undervaluation of the stock.
NEGATIVE
- Consistent share selling by top executives (COO and President) may signal caution about short-term prospects.
- Q1 2025 net income declined by 9.5% year-over-year, with core income dropping 15.3%.
- The deteriorating combined ratio and rising policy acquisition costs are pressuring profit margins.
- Increased competition in the Florida insurance market and rising reinsurance costs continue to pose challenges.
Expert
Despite volatility in the U.S. coastal insurance market, ACIC maintains an excellent combined ratio of 65%, demonstrating solid underwriting capabilities. The contrasting trading patterns between executives and directors suggest a balance point between short-term performance challenges and long-term value, with the current depressed valuation potentially offering an entry opportunity at the low point of the insurance cycle.
Previous Closing Price
$10.97
-0.06(0.54%)
Average Insider Trading Data Over the Past Year
$11.61
Purchase Average Price
$11.49
Sale Average Price
$249.72K
Purchase Amount
$2.35M
Sale Amount
Transaction related to News
Trading Date | Filing Date | Insider | Title | Type | Avg. Price | Trans. Value |
---|---|---|---|---|---|---|
05/23/2025 | 05/23/2025 | Sale | $ |
A notable insider transaction recently occurred at $ACIC (American Coastal Insurance Corp), a small Florida-based insurer. On May 15, 2025, Director Sherrill Hudson purchased 10,000 shares at $11.00 per share, totaling approximately $110,000. This purchase is particularly significant as it came immediately following the company's Q1 earnings release and amid a declining share price. $ACIC's stock has experienced a considerable pullback from its December 2024 highs of around $13.70, currently trading near the $11 mark—a decline of approximately 20%. This downturn aligns with broader weakness across the insurance sector in recent months. American Coastal Insurance Corp, which rebranded from United Insurance Holdings Corp in August 2023, specializes in property and casualty insurance primarily in Florida. The company focuses on residential and commercial property insurance for homeowners, condominiums, and residential associations, particularly in coastal regions. With a market capitalization of approximately $520 million, ACIC falls into the small-cap category. A fascinating contrast emerges when examining insider trading patterns. Senior executives have been consistent sellers, with COO Christopher Griffith selling over 60,000 shares in early March 2025 at an average price of $11.94, and President Brad Martz offloading 50,000 shares at $12.05 on March 14. This continues a pattern of executive selling observed throughout late 2024. Conversely, board directors have demonstrated confidence through purchasing activity. Beyond Hudson's recent acquisition, Director Michael Hogan bought 8,000 shares in September 2024, and Director Patrick Maroney acquired approximately 3,500 shares in December 2024. This divergence may reflect differing perspectives on the company's short-term performance versus long-term value proposition. The company reported its Q1 2025 financial results on May 8, posting adjusted earnings per share of $0.42, which exceeded analyst expectations of $0.40 but represented a 16% decrease from the prior year's $0.50. Revenue came in at $68.27 million, falling short of the forecast $74.63 million and showing a slight year-over-year decline of 0.7%. The combined ratio deteriorated to 65%, primarily due to increased policy acquisition costs and reduced ceding commission income following changes in quota share reinsurance arrangements. Despite this performance deceleration, ACIC continues to demonstrate financial metrics that outperform industry averages. A combined ratio of 65%, while worse than previous quarters, still indicates strong underwriting discipline and profitability compared to industry standards. The company also demonstrated a commitment to shareholder returns by declaring a special dividend of $0.50 per share in December, which triggered a significant positive stock price reaction. A key strategic development worth noting is the April 2025 announcement of the sale of ACIC's personal lines subsidiary, Interboro Insurance Company, for approximately $26.4 million. This divestiture appears to be part of a strategic shift to focus resources on core business segments and optimize operational efficiency. The analyst community maintains a generally positive outlook on $ACIC, with an average recommendation of 'buy' and a median 12-month price target of $16.00, suggesting a potential upside of approximately 45% from current levels. The stock's price-to-earnings ratio of 7.57 indicates a potential undervaluation, though this may reflect both the recent earnings slowdown and broader challenges facing the insurance industry. Taken together, Director Hudson's recent purchase represents a positive signal of insider confidence in the company's intrinsic value following the share price decline. However, the persistent selling pattern among top executives and the earnings deceleration suggest short-term uncertainties. Investors should closely monitor upcoming Q2 results and broader industry developments, particularly trends in the Florida insurance market, before making investment decisions.